UBS O'Connor’s NxStage Medical Inc. NXTM Stock Holding History

UBS O'Connor’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,244,006	Closed	-$35.6M	–	198
2018 Q4	$35.6M	Sell	1,244,006 -88,287	-7%	-$2.51M	1.28%	20
2018 Q3	$37.2M	Buy	1,332,293 +394,802	+42%	+$11.1M	0.85%	22
2018 Q2	$26.2M	Buy	937,491 +304,033	+48%	+$8.15M	0.52%	38
2018 Q1	$15.7M	Buy	633,458 +73,777	+13%	+$1.79M	0.3%	49
2017 Q4	$13.6M	Buy	559,681 +384,681	+220%	+$10.1M	0.24%	70
2017 Q3	$4.83M	Buy	+175,000	New	+$4.67M	0.07%	196

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

UBS O'Connor's NXTM Position: Q1 2019 in Review

UBS O'Connor sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,244,006 shares — an estimated $35.6M sold.

UBS O'Connor first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $37.2M in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

UBS O'Connor reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
UBS O'Connor sold 1,244,006 NxStage Medical Inc. shares in Q1 2019, an estimated $35.6M.
UBS O'Connor first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
UBS O'Connor's NxStage Medical Inc. position peaked at $37.2M in Q3 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on UBS O'Connor's 13F filing for Q1 2019, filed 13 May 2019.